Similar articles

• The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.

  Fung YK, Uretsky NJ. Fung YK, et al. J Pharmacol Exp Ther. 1980 Sep;214(3):651-6. J Pharmacol Exp Ther. 1980. PMID: 6772760
• Action of anticholinergic drugs on striatal dopamine.

  Snyder SH. Snyder SH. Pharmacol Ther B. 1976;2(1):65-70. doi: 10.1016/0306-039x(76)90019-2. Pharmacol Ther B. 1976. PMID: 772723 Review. No abstract available.
• Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.

  Fuxe K, Ungerstedt U. Fuxe K, et al. Pharmacol Ther B. 1976;2(1):41-7. doi: 10.1016/0306-039x(76)90017-9. Pharmacol Ther B. 1976. PMID: 817332 Review. No abstract available.
• Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway.

  Oberlander C, Euvrard C, Dumont C, Boissier JR. Oberlander C, et al. Eur J Pharmacol. 1979 Dec 7;60(2-3):163-70. doi: 10.1016/0014-2999(79)90215-2. Eur J Pharmacol. 1979. PMID: 575095 No abstract available.
• Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice.

  Thornburg JE, Moore KE. Thornburg JE, et al. J Pharmacol Exp Ther. 1975 Jan;192(1):42-9. J Pharmacol Exp Ther. 1975. PMID: 1168250